Evidence map›Paper›PMID 35730603›Full record

ArticleInternational journal of molecular medicine2022

[Corrigendum] miR‑135 regulated breast cancer proliferation and epithelial‑mesenchymal transition acts by the Wnt/β‑catenin signaling pathway.

Daqiong Jiang, Bo Zhou, Yan Xiong, Hongbing Cai

Abstract readPublished Erratum
In one paragraph

Article in International journal of molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Daqiong JiangDepartment of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Bo ZhouDepartment of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Yan XiongDepartment of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Hongbing CaiDepartment of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 2A on p. 1626, the data panels showing the results for the 'Bright/Blank control' and 'Bright/mi‑135 inhibitors' experiments appeared to be identical; furthermore, in Fig. 8 on p. 1632, Figs. 8B and D appeared to contain identical data, even though the contrast settings for the two sets of panels were a little different. The authors have re‑examined their original data, and regret that Figs. 2 and 8 were inadvertently both assembled incorrectly, as identified by the external reader. However, the authors retained their original data, and were able to reassemble both these figures correctly. The revised versions of Figs. 2 and 8 are shown on the next two pages, now including the correct data for the 'Bright/Blank control' experiment in Fig. 2A and the correct immunofluorescence data in Fig. 8B. Note that the revised data shown for these figures do not affect the overall conclusions reported in the paper. The authors express their gratitude to the Editor of

Indexed as

breast cancerepithelial‑mesenchymal transitionmiR‑135proliferationWnt/β‑catenin pathway

Identifiers

PMID35730603
PMCPMC9256075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.